Impact of prostate volume on the active surveillance in prostate cancer

被引:0
|
作者
Beaujouan, Florent [1 ]
Bertherat, Walter [2 ]
Hammoudi, Zakaria [1 ]
Chicaud, Marie [1 ]
Descazeaud, Aurelien [1 ]
机构
[1] Univ Hosp Ctr Dupuytren, Dept Urol Surg & Androl, 16 rue Petiniaud-Beaupeyrat, F-87000 Limoges, France
[2] Perigueux Hosp Ctr, Dept Urol Surg & Androl, Perigueux, France
关键词
Prostatic neoplasms; active surveillance; prostate-specific antigen; prostatic hyperplasia; prognostic factors; FOLLOW-UP; ANTIGEN KINETICS; GUIDELINES; MANAGEMENT; DIAGNOSIS; OUTCOMES; PREDICT; UPDATE; BIOPSY; COHORT;
D O I
10.1177/20514158241303972
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the influence of the prostate volume (PVo) in the management of patients in active surveillance (AS) for prostate cancer. Materials and methods: A retrospective analysis of clinical, biological, histological and radiological data collected between 2010 and 2021 was performed for patients included in an AS protocol in a university hospital. The impact of initial PVo on the subsequent risk of exiting AS was evaluated. Results: In total, 109 patients were included in this analysis with a mean follow-up period of 52.74 +/- 31 months, 50% were out of AS by the end of the follow-up period. The risk of exiting the AS protocol was significantly associated to the PVo: patients with smaller PVo had an increased risk of exiting AS (p = 0.025). The maximal percentage of core invasion was the only initial predictive parameter for exiting the AS protocol on multivariate analysis of the global cohort (p = 0.010) and in the sub-group of patients having PVo <= 45 mL (p = 0.013). In the group having a PVo > 45 mL, no single initial parameter was significantly associated to a risk of exiting AS. Conclusion: Patients having small-sized prostate seemed to be at higher risk of exiting AS during follow-up.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Active surveillance for localized prostate cancer
    Tinay, Ilker
    Turkeri, Levent
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (02): : 114 - 118
  • [32] Active surveillance for localized prostate cancer
    Drouin, S. J.
    Roupret, M.
    Hamdy, F.
    Mottet, N.
    PROGRES EN UROLOGIE, 2010, 20 : S181 - S185
  • [33] Active surveillance of prostate cancer: An update
    Chaloupka M.
    Westhofen T.
    Kretschmer A.
    Grimm T.
    Stief C.
    Apfelbeck M.
    best practice onkologie, 2019, 14 (10) : 442 - 451
  • [34] The inconveniences of active surveillance in prostate cancer
    Sanchez-de-Badajoz, E.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (02): : 69 - 71
  • [35] EFFECT OF INTRA-OBSERVER VARIATION IN PROSTATE VOLUME CALCULATIONS IN PROSTATE CANCER ACTIVE SURVEILLANCE GROUP
    Ko, Joan
    Landis, Patricia
    Carter, H. Ballentine
    Partin, Alan
    JOURNAL OF UROLOGY, 2011, 185 (04): : E654 - E655
  • [36] Role of Prostate MRI in the Setting of Active Surveillance for Prostate Cancer
    Galgano, Samuel J.
    Glaser, Zachary A.
    Porter, Kristin K.
    Rais-Bahrami, Soroush
    MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 49 - 67
  • [37] Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance
    Tosoian, Jeffrey J.
    Mamawala, Mufaddal
    Patel, Hiten D.
    Alam, Ridwan
    Epstein, Jonathan I.
    Ross, Ashley E.
    Carter, Ballentine
    JOURNAL OF UROLOGY, 2018, 199 (04): : 954 - 959
  • [38] LIVING WITH UNTREATED PROSTATE CANCER: THE IMPACT OF ACTIVE SURVEILLANCE ON QUALITY OF LIFE
    Venderbos, Lionne
    van den Bergh, Roderick
    Roobol, Monique
    Schroder, Fritz
    Steyerberg, Ewout
    Bangma, Chris
    Essink-Bot, Marie-Louise
    JOURNAL OF UROLOGY, 2012, 187 (04): : E405 - E405
  • [39] Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer
    Detsky, Jay S.
    Ghiam, Alireza Fotouhi
    Mamedov, Alexandre
    Commisso, Kristina
    Commisso, Angela
    Zhang, Liying
    Liu, Stanley
    Klotz, Laurence
    Loblaw, Andrew
    Vesprini, Danny
    JOURNAL OF UROLOGY, 2020, 204 (05): : 934 - 940
  • [40] Impact of compliance on outcomes for patients on active surveillance for prostate cancer.
    Detsky, Jay
    Ghiam, Alireza Fotouhi
    Mamedov, Alexandre
    Commisso, Kristina
    Commisso, Angela
    Klotz, Laurence
    Liu, Stanley K.
    Loblaw, Andrew
    Vesprini, Danny
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)